-
3,4-苯並芘
鎖定
- 中文名
- 3,4-苯並芘
- 外文名
- 3,4—Benzopyrene**
- 別 名
- 苯並[def]䓛*Benzo(def)Chrysene,苯並[A]芘
- 化學式
- C20H12
- 分子量
- 252.31
- CAS登錄號
- 50-32-8
- EINECS登錄號
- 200-028-5
- 熔 點
- 177-180°C
- 沸 點
- 495°C
- 外 觀
- 黃色至棕色粉末
- 閃 點
- 495°C
- 安全性描述
- 高毒
- 危險性符號
- T,N,F
- UN危險貨物編號
- 2811
3,4-苯並芘簡介
中文名稱:苯並(a)芘
中文同義詞:苯並[A]芘;苯並(a)芘;3,4-苯並芘;苯並芘;1,2-苯並芘;苯並芘標準品;苯並(A)芘(標樣)3,4-BENZOPYRENE
英文名稱:BENZO[A]PYRENE
英文同義詞:3,4-benz(a)pyrene;3,4-Benz[a]pyrene;3,4-Benzopirene;3,4-Benzpyren;3,4-BP;BP;coaltarpitchvolatiles:benzo(a)pyrene;Rcra waste number U022
CAS號:50-32-8
分子式:C20H12
3,4-苯並芘編號系統
CAS號:50-32-8
MDL號:MFCD00003602
EINECS號:200-028-5
RTECS號:DJ3675000
3,4-苯並芘物性數據
性狀:黃色至棕色粉末。
密度(g/mL,25/4℃):1.286
熔點(ºC):177-180
沸點(ºC,常壓):495
閃點(ºC):495°C
蒸氣壓(kPa,25 ºC):0.665×10-19 kPa
3,4-苯並芘分子結構數據
1、摩爾折射率:90.30
2、摩爾體積(cm3/mol):196.0
3、等張比容(90.2K):553.5
4、表面張力(dyne/cm):63.4
3,4-苯並芘計算化學數據
1.疏水參數計算參考值(XlogP):無
2.氫鍵供體數量:0
3.氫鍵受體數量:0
4.可旋轉化學鍵數量:0
5.互變異構體數量:無
6.拓撲分子極性表面積0
7.重原子數量:20
8.表面電荷:0
9.複雜度:372
10.同位素原子數量:0
11.確定原子立構中心數量:0
12.不確定原子立構中心數量:0
13.確定化學鍵立構中心數量:0
14.不確定化學鍵立構中心數量:0
3,4-苯並芘貯存方法
3,4-苯並芘用途
1. 組織化學測定脂類(呈藍或藍白色熒光,褪色快,不能作永久標本)。癌症的研究。
2. 常作為環境中致癌多環芳烴污染指標物質。
3. 在工業上無生產和使用價值,一般只作為生產過程中形成的副產物隨廢棄排放。
3,4-苯並芘3,4-苯並芘的危害及預防
1)致癌性
苯並[a]芘對人類和動物來説是一種很強的致癌物質,最初發現其可導致皮膚癌,後經深入研究發現對機體各臟器如肺、肝、食道、胃腸等均可致癌。苯並[a]芘是最早發現的致癌物質,自1775 年報道英國煙囱清潔工陰囊癌的發病率高這一現象以來,經多年的研究證明苯並[a]芘是一種主要的致癌因素。動物試驗表明小鼠經口給予苯並[a]芘,總量為1mg的胃癌誘癌率為47.8%,總劑量為10mg的誘癌率高達70%。根據流行病學調查,長期食用熏製食品與某些瘤腫發生有一定關係,海邊居民因食用大量鹹魚及燻魚,其胃腸道和呼吸道的癌症發病率較內陸高 3倍;冰島的胃癌死亡率為125.5人/10萬人,可能與該地區居民喜吃煙燻食品有關;日本也是胃癌發病率很高的國家,一些居民有在炭火上烤魚吃的習慣。苯並[a]芘引起癌症的潛伏期很長,一般為20年~ 25 年,發病年齡在40 歲~45 歲。現已有許多材料證實,大氣中苯並[a]芘的濃度與肺癌發病率有關。德國有報道大氣中苯並[a]芘濃度為 10μg/100cm3~12.5 μg/100cm3時,居民肺癌死亡率為25人/10萬人;當苯並[a]芘濃度達到17μg/100cm3~19 μg/100cm3,居民肺癌死亡率為 35人 /10 萬人~ 38 人/10 萬人。分析認為,如4 年內進食苯並[a]芘總量達80 000μg,就有可能致癌。因此,人體每日進食苯並[a]芘的量不能超過10μg。
2) 致突變性
所謂的致突變性是環境中某些外界因素在一定條件下引起機體的遺傳物質發生突然的根本的變異性能。這種突變造成遺傳物質複製錯亂,有時可引起形態和結構及功能的改變,導致遺傳缺陷和疾病。常用的化學物致突變方法有細菌回覆突變試驗、鼠傷寒沙門菌回變試驗 (Ames 試驗)、微核試驗、染色體畸變試驗和程序外DNA 合成試驗。苯並[a]芘同時也具有致突變作用,在Ames 實驗及其他細菌突變、細菌DNA 修復、姐妹染色單體交換、染色體畸變、哺乳類細胞培養及哺乳類動物精子畸變等實驗中均呈陽性反應。
預防措施
為防止苯並[a]芘污染食品,可採取以下措施:加強環境治理,防止工業三廢中苯並[a]芘對水域、土壤、空氣和植物造成污染;改變生產方式,禁止在柏油路面晾曬收穫的農作物;不用苯並[a]芘含量高的材料生產或包裝食品;改進烹調和加工方法,儘量避免食品成分熱解和熱聚,以減少苯並[a]芘形成;改變飲食習慣,儘量少吃燒烤、燻烤肉製品,不食用烤焦、炭化的肉製品,以減少苯並[a]芘的攝入量;維生素 A及白菜、蘿蔔等十字花科蔬菜有降解3, 4 - 苯並芘的作用,宜經常食用;採取措施對污染的食品進行去毒處理,如用活性炭吸附油脂中的有毒物質,用日光或紫外線照射糧食,以降低食物中的苯並[a]芘含量。
[4]
3,4-苯並芘安全信息
危險運輸編碼:UN 3077 9/PG 3
安全標識:S45S53S60S61S1
3,4-苯並芘物質毒性
編號 | 毒性類型 | 測試方法 | 測試對象 | 使用劑量 | 毒性作用 |
---|---|---|---|---|---|
1 | 急性毒性 | 皮下注射 | 大鼠 | 50 mg/kg | 詳細作用沒有報告除致死劑量以外的其他值 |
2 | 急性毒性 | 腹腔注射 | 小鼠 | 500 mg/kg | 詳細作用沒有報告除致死劑量以外的其他值 |
3 | 急性毒性 | Intrarenal | 蛙 | 9 mg/kg | 詳細作用沒有報告除致死劑量以外的其他值 |
4 | 慢性毒性 | 口服 | 大鼠 | 9 mg/kg/90D-I | 1.腎、輸尿管和膀胱毒性——腎小管發生變化 (包括急性腎功能衰竭,急性腎小管壞死) |
5 | 慢性毒性 | 口服 | 大鼠 | 2250 mg/kg/5W-I | 1.血液毒性——脾發生變化 2.免疫系統毒性——免疫應答下降 3.營養和代謝系統毒性——體重下降或體重增加速率下降 |
6 | 慢性毒性 | 皮下注射 | 小鼠 | 400 mg/kg/2W-I | 1.免疫系統毒性——體液免疫應答減少 |
7 | 慢性毒性 | 未報告 | 小鼠 | 180 mg/kg/12D-I | 1.免疫系統毒性——未知 |
8 | 眼部毒性 | 皮膚表面 | 小鼠 | 14 ug | 作用較輕 |
9 | 突變毒性 | 鼠傷寒沙門氏菌 | 2 ug/plate | ||
10 | 突變毒性 | 鼠傷寒沙門氏菌 | 312 ng/plate | ||
11 | 突變毒性 | 鼠傷寒沙門氏菌 | 1 mg/L | ||
12 | 突變毒性 | 鼠傷寒沙門氏菌 | 147 gm/L | ||
13 | 突變毒性 | 鼠傷寒沙門氏菌 | 3900 pmol/plate | ||
14 | 突變毒性 | 大腸桿菌 | 1 umol/L | ||
15 | 突變毒性 | 大腸桿菌 | 700 pmol/tube | ||
16 | 突變毒性 | 大腸桿菌 | 200 nmol/plate | ||
17 | 突變毒性 | 大腸桿菌 | 70 ug/well | ||
18 | 突變毒性 | 大腸桿菌 | 500 mg/L | ||
19 | 突變毒性 | 大腸桿菌 | 400 ng/plate | ||
20 | 突變毒性 | 枯草芽孢桿菌 | 5 gm/L | ||
21 | 突變毒性 | 枯草芽孢桿菌 | 200 ug/disc | ||
22 | 突變毒性 | 微生物 | 3 umol/L | ||
23 | 突變毒性 | 微生物 | 1 mg/L | ||
24 | 突變毒性 | 微生物 | 200 ug/L | ||
25 | 突變毒性 | 微生物 | 100 ug/L | ||
26 | 突變毒性 | 微生物 | 11 ng/L | ||
27 | 突變毒性 | 微生物 | 100 umol/L | ||
28 | 突變毒性 | 口服 | 黑腹果蠅 | 250 umol/L | |
29 | 突變毒性 | 口服 | 黑腹果蠅 | 100 mg/L | |
30 | 突變毒性 | 口服 | 黑腹果蠅 | 1 mmol/L | |
31 | 突變毒性 | 腸外 | 黑腹果蠅 | 5 mmol/L | |
32 | 突變毒性 | 口服 | 黑腹果蠅 | 100 umol/L | |
33 | 突變毒性 | 釀酒酵母 | 1 gm/L | ||
34 | 突變毒性 | 釀酒酵母 | 50 mg/L | ||
35 | 突變毒性 | 釀酒酵母 | 10 ug/plate | ||
36 | 突變毒性 | 釀酒酵母 | 150 mg/L | ||
37 | 突變毒性 | 多種途徑 | 非哺乳動物 | 1000 ppb | |
38 | 突變毒性 | 多種途徑 | 非哺乳動物 | 10 ppb/8D (持續) | |
39 | 突變毒性 | 腹腔注射 | 魚類 | 10 mg/kg | |
40 | 突變毒性 | 口服 | 昆蟲 | 500 ppm | |
41 | 突變毒性 | 多種途徑 | 非哺乳動物 | 60 ppb | |
42 | 突變毒性 | 口服 | 魚類 | 125 umol/kg/5D (間斷) | |
43 | 突變毒性 | 非哺乳動物 | 1700 nmol/L | ||
44 | 突變毒性 | 腹腔注射 | 魚類 | 20 mg/kg | |
45 | 突變毒性 | 鮭魚睾丸 | 5 ug/1H (持續) | ||
46 | 突變毒性 | 鮭魚細胞 | 80 umol/L | ||
47 | 突變毒性 | 腹腔注射 | 魚類 | 125 mg/kg | |
48 | 突變毒性 | 魚類肝 | 10 umol/L | ||
49 | 突變毒性 | 魚類肝 | 20 nmol/L | ||
50 | 突變毒性 | 魚類肝 | 1 umol/L | ||
51 | 突變毒性 | 魚類 細胞 | 10 umol/L | ||
52 | 突變毒性 | 皮膚表面 | 魚類 | 100 ng/L | |
53 | 突變毒性 | 魚類 細胞 | 100 ug/L/48H | ||
54 | 突變毒性 | 多種途徑 | 非哺乳動物 | 10 ug/L | |
55 | 突變毒性 | 魚類成纖維細胞 | 5 mg/L | ||
56 | 突變毒性 | 人類細胞 | 10 mg/L | ||
57 | 突變毒性 | 人類淋巴細胞 | 50 umol/L | ||
58 | 突變毒性 | 人類淋巴細胞 | 4 mg/L | ||
59 | 突變毒性 | 人類肝 | 100 nmol/L | ||
60 | 突變毒性 | 人類細胞 | 10 mg/L | ||
61 | 突變毒性 | 人類成纖維細胞 | 3200 ug/L | ||
62 | 突變毒性 | 人類淋巴細胞 | 1 umol/L/72H | ||
63 | 突變毒性 | 人類成纖維細胞 | 10 umol/L | ||
64 | 突變毒性 | 人類成纖維細胞 | 10 mg/L | ||
65 | 突變毒性 | 人類細胞 | 1500 nmol/L | ||
66 | 突變毒性 | 海拉細胞 | 1500 nmol/L | ||
67 | 突變毒性 | 人類白細胞 | 500 umol/L | ||
68 | 突變毒性 | 人類細胞 | 400 nmol/L | ||
69 | 突變毒性 | 人類細胞 | 1 umol/L | ||
70 | 突變毒性 | 海拉細胞 | 1 mmol/L | ||
71 | 突變毒性 | 人類肺 | 1 umol/L | ||
72 | 突變毒性 | 人類肝 | 1 umol/L | ||
73 | 突變毒性 | 海拉細胞 | 1500 nmol/L | ||
74 | 突變毒性 | 人類細胞 | 4 umol/L | ||
75 | 突變毒性 | 人類細胞 | 10 umol/L | ||
76 | 突變毒性 | 人類細胞 | 3 mg/L | ||
77 | 突變毒性 | 人類細胞 | 5 umol/L | ||
78 | 突變毒性 | 人類成纖維細胞 | 1 mg/L | ||
79 | 突變毒性 | 人類乳腺 | 10 umol/L | ||
80 | 突變毒性 | 人類細胞 | 150 umol/L | ||
81 | 突變毒性 | 人類細胞 | 40 umol/L | ||
82 | 突變毒性 | 人類成纖維細胞 | 40 umol/L/24H | ||
83 | 突變毒性 | 人類白細胞 | 1 mg/L | ||
84 | 突變毒性 | 人類淋巴細胞 | 2400 ug/L | ||
85 | 突變毒性 | 人類白細胞 | 50 umol/L | ||
86 | 突變毒性 | 人類淋巴細胞 | 1 umol/L/72H | ||
87 | 突變毒性 | 人類成纖維細胞 | 1 mg/L | ||
88 | 突變毒性 | 人類肝 | 1 mmol/L | ||
89 | 突變毒性 | 人類細胞 | 100 nmol/L | ||
90 | 突變毒性 | 人類成纖維細胞 | 100 nmol/L | ||
91 | 突變毒性 | 人類淋巴細胞 | 3 umol/L | ||
92 | 突變毒性 | 人類淋巴細胞 | 1200 nmol/L | ||
93 | 突變毒性 | 腹腔注射 | 大鼠 | 800 mg/kg | |
94 | 突變毒性 | 口服 | 大鼠 | 125 mg/kg | |
95 | 突變毒性 | 口服 | 大鼠 | 10 mg/kg | |
96 | 突變毒性 | 氣管 | 大鼠 | 10 mg/kg | |
97 | 突變毒性 | 大鼠細胞 | 1 mg/L | ||
98 | 突變毒性 | 大鼠肝 | 100 umol/L | ||
99 | 突變毒性 | 大鼠細胞 | 4 ug/tube | ||
100 | 突變毒性 | 口服 | 大鼠 | 200 mg/kg | |
101 | 突變毒性 | 大鼠肺 | 2 umol/L | ||
102 | 突變毒性 | 大鼠胎兒 | 15400 ug/L | ||
103 | 突變毒性 | 靜脈注射 | 大鼠 | 140 ug/kg | |
104 | 突變毒性 | 皮膚表面 | 大鼠 | 800 nmol/kg | |
105 | 突變毒性 | 腹腔注射 | 大鼠 | 40 mg/kg | |
106 | 突變毒性 | 大鼠肝 | 80 umol/L | ||
107 | 突變毒性 | 大鼠成纖維細胞 | 1500 umol/L | ||
108 | 突變毒性 | 大鼠細胞 | 1500 nmol/L | ||
109 | 突變毒性 | 氣管 | 大鼠 | 50 mg/kg | |
110 | 突變毒性 | 大鼠細胞 | 1 umol/L | ||
111 | 突變毒性 | 口服 | 大鼠 | 240 mg/kg/8D (持續) | |
112 | 突變毒性 | 大鼠細胞 | 31 umol/L | ||
113 | 突變毒性 | 大鼠肝 | 5 umol/L | ||
114 | 突變毒性 | 大鼠細胞 | 100 mmol/L | ||
115 | 突變毒性 | 口服 | 大鼠 | 62500 ug/kg | |
116 | 突變毒性 | 大鼠胎兒 | 500 ug/L | ||
117 | 突變毒性 | 大鼠肝 | 10 umol/L | ||
118 | 突變毒性 | 大鼠細胞 | 1 mg/L | ||
119 | 突變毒性 | 腹腔注射 | 大鼠 | 40 mg/kg | |
120 | 突變毒性 | 大鼠細胞 | 5 mg/L | ||
121 | 突變毒性 | 大鼠 鼠傷寒沙門氏菌 | 10 mg/kg | ||
122 | 突變毒性 | 大鼠卵巢 | 2 mg/kg | ||
123 | 突變毒性 | 大鼠肝 | 3 umol/L | ||
124 | 突變毒性 | 靜脈注射 | 大鼠 | 50 mg/kg | |
125 | 突變毒性 | 腹腔注射 | 大鼠 | 800 mg/kg | |
126 | 突變毒性 | 未報告 | 大鼠 | 423 mg/kg | |
127 | 突變毒性 | 大鼠細胞 | 100 ug/L | ||
128 | 突變毒性 | 大鼠肝 | 1600 pmol/L | ||
129 | 突變毒性 | 大鼠細胞 | 500 umol/L | ||
130 | 突變毒性 | 大鼠腹水瘤細胞 | 1 mmol/L | ||
131 | 突變毒性 | 腹腔注射 | 大鼠 | 25 mg/kg | |
132 | 突變毒性 | 大鼠細胞 | 18850 nmol/L | ||
133 | 突變毒性 | 大鼠乳腺 | 1 mg/L | ||
134 | 突變毒性 | 大鼠肝 | 1 umol/L | ||
135 | 突變毒性 | 小鼠成纖維細胞 | 250 ug/L | ||
136 | 突變毒性 | 口服 | 小鼠 | 40 mg/kg | |
137 | 突變毒性 | 皮膚表面 | 小鼠 | 20 ug/kg | |
138 | 突變毒性 | 腹腔注射 | 小鼠 | 30 mg/kg | |
139 | 突變毒性 | 小鼠淋巴細胞 | 250 ug/L | ||
140 | 突變毒性 | 口服 | 小鼠 | 80 mg/kg | |
141 | 突變毒性 | 腸外 | 小鼠 | 100 mg/kg | |
142 | 突變毒性 | 口服 | 小鼠 | 100 mg/kg/8D (間斷) | |
143 | 突變毒性 | 小鼠淋巴細胞 | 500 umol/L | ||
144 | 突變毒性 | 小鼠細胞 | 100 ug/L | ||
145 | 突變毒性 | 小鼠胎兒 | 100 ug/L | ||
146 | 突變毒性 | 小鼠成纖維細胞 | 500 ug/L | ||
147 | 突變毒性 | 皮膚表面 | 小鼠 | 4 mg/kg | |
148 | 突變毒性 | 小鼠肝 | 6 umol/L | ||
149 | 突變毒性 | 小鼠成纖維細胞 | 3 mg/L | ||
150 | 突變毒性 | 小鼠胎兒 | 1200 nmol/L | ||
151 | 突變毒性 | 皮膚表面 | 小鼠 | 40 umol/kg | |
152 | 突變毒性 | 皮膚表面 | 小鼠 | 8 mg/kg | |
153 | 突變毒性 | 口服 | 小鼠 | 240 mg/kg | |
154 | 突變毒性 | 口服 | 小鼠 | 12 mg/kg | |
155 | 突變毒性 | 小鼠成纖維細胞 | 7 umol/L | ||
156 | 突變毒性 | 小鼠細胞 | 100 umol/L | ||
157 | 突變毒性 | 腹腔注射 | 小鼠 | 100 mg/kg | |
158 | 突變毒性 | 小鼠肝 | 1 umol/L | ||
159 | 突變毒性 | 皮膚表面 | 小鼠 | 200 mg/L | |
160 | 突變毒性 | 腹腔注射 | 小鼠 | 50 mg/kg | |
161 | 突變毒性 | 鼠傷寒沙門氏菌 | 100 mg/kg | ||
162 | 突變毒性 | 腹腔注射 | 小鼠 | 50 mg/kg | |
163 | 突變毒性 | 口服 | 小鼠 | 25 mg/kg | |
164 | 突變毒性 | 小鼠白細胞 | 100 ug/L/17H (持續) | ||
165 | 突變毒性 | 小鼠成纖維細胞 | 5 umol/L | ||
166 | 突變毒性 | 小鼠淋巴細胞 | 2500 ug/L | ||
167 | 突變毒性 | 小鼠肺 | 25 mg/kg | ||
168 | 突變毒性 | 小鼠胎兒 | 1 umol/L | ||
169 | 突變毒性 | 小鼠成纖維細胞 | 100 nmol/L | ||
170 | 突變毒性 | 腹腔注射 | 小鼠 | 20 mg/kg | |
171 | 突變毒性 | 靜脈注射 | 小鼠 | 100 mg/kg | |
172 | 突變毒性 | 小鼠骨髓 | 30 umol/L | ||
173 | 突變毒性 | 小鼠細胞 | 30 umol/L | ||
174 | 突變毒性 | 腹腔注射 | 小鼠 | 750 mg/kg | |
175 | 突變毒性 | 小鼠淋巴細胞 | 4500 ug/L | ||
176 | 突變毒性 | 小鼠胎兒 | 3 umol/L | ||
177 | 突變毒性 | 小鼠成纖維細胞 | 200 nmol/L | ||
178 | 突變毒性 | 小鼠 大腸桿菌 | 50464 ug/kg | ||
179 | 突變毒性 | 腹腔注射 | 小鼠 | 100 mg/kg/5D | |
180 | 突變毒性 | 腸外 | 小鼠 | 500 mg/kg | |
181 | 突變毒性 | 未報告 | 小鼠 | 200 mg/kg | |
182 | 突變毒性 | 倉鼠胎兒 | 100 ug/L | ||
183 | 突變毒性 | 倉鼠胎兒 | 4 umol/L | ||
184 | 突變毒性 | 倉鼠卵巢 | 1 mg/L | ||
185 | 突變毒性 | 倉鼠肺 | 25 nmol/plate | ||
186 | 突變毒性 | 倉鼠卵巢 | 5 mg/L | ||
187 | 突變毒性 | 倉鼠細胞 | 1 umol/L | ||
188 | 突變毒性 | 倉鼠細胞 | 1200 nmol/L | ||
189 | 突變毒性 | 倉鼠肺 | 10 ug/L | ||
190 | 突變毒性 | 腹腔注射 | 倉鼠 | 500 mg/kg | |
191 | 突變毒性 | 倉鼠胎兒 | 400 ug/L | ||
192 | 突變毒性 | 倉鼠腎 | 80 ug/L | ||
193 | 突變毒性 | 倉鼠成纖維細胞 | 1 mg/L | ||
194 | 突變毒性 | 腸外 | 倉鼠 | 1 mg/L | |
195 | 突變毒性 | 倉鼠肺 | 30 umol/L/2H | ||
196 | 突變毒性 | 倉鼠卵巢 | 100 umol/L | ||
197 | 突變毒性 | 倉鼠胎兒 | 500 ug/L | ||
198 | 突變毒性 | 倉鼠細胞 | 800 nmol/L | ||
199 | 突變毒性 | 倉鼠胎兒 | 300 ug/L | ||
200 | 突變毒性 | 倉鼠胎兒 | 1 mg/L | ||
201 | 突變毒性 | 倉鼠細胞 | 100 nmol/L | ||
202 | 突變毒性 | 倉鼠細胞 | 1 umol/L | ||
203 | 突變毒性 | 倉鼠肝 | 10 umol/L | ||
204 | 突變毒性 | 倉鼠細胞 | 100 ug/L | ||
205 | 突變毒性 | 倉鼠肺 | 6 mg/L | ||
206 | 突變毒性 | 倉鼠胎兒 | 60 ug/L | ||
207 | 突變毒性 | 倉鼠細胞 | 150 umol/L | ||
208 | 突變毒性 | 倉鼠成纖維細胞 | 10 umol/L | ||
209 | 突變毒性 | 倉鼠細胞 | 5 mg/L | ||
210 | 突變毒性 | 倉鼠卵巢 | 3970 nmol/L | ||
211 | 突變毒性 | 吸入 | 倉鼠 | 100 ug/L/5D (間斷) | |
212 | 突變毒性 | 腹腔注射 | 倉鼠 | 200 mg/kg | |
213 | 突變毒性 | 倉鼠肺 | 100 mg/L | ||
214 | 突變毒性 | 倉鼠成纖維細胞 | 1 mg/L | ||
215 | 突變毒性 | 腹腔注射 | 倉鼠 | 900 mg/kg/24H | |
216 | 突變毒性 | 倉鼠卵巢 | 5610 nmol/L | ||
217 | 突變毒性 | 倉鼠胎兒 | 10 ng/L | ||
218 | 突變毒性 | 倉鼠肺 | 1 ug/L | ||
219 | 突變毒性 | 倉鼠成纖維細胞 | 500 umol/L | ||
220 | 突變毒性 | 吸入 | 倉鼠 | 100 ug/L/5D (間斷) | |
221 | 突變毒性 | 未報告 | 倉鼠 | 25 mg/kg | |
222 | 突變毒性 | 倉鼠細胞 | 9900 nmol/L | ||
223 | 突變毒性 | 倉鼠肝 | 1 mg/L | ||
224 | 突變毒性 | 倉鼠肝 | 110 ug/L | ||
225 | 突變毒性 | 腹腔注射 | 倉鼠 | 200 mg/kg | |
226 | 突變毒性 | 倉鼠肺 | 1 mg/L | ||
227 | 突變毒性 | 倉鼠成纖維細胞 | 1 mg/L | ||
228 | 突變毒性 | 倉鼠胎兒 | 500 ug/L | ||
229 | 突變毒性 | 腹腔注射 | 倉鼠 | 25 mg/kg/5D | |
230 | 突變毒性 | 倉鼠卵巢 | 1 mmol/L | ||
231 | 突變毒性 | 豚鼠 細胞 | 10 mg/L | ||
232 | 突變毒性 | 猴肺 | 25 umol/L | ||
233 | 突變毒性 | 猴細胞 | 1 umol/L | ||
234 | 突變毒性 | 猴細胞 | 25 umol/L | ||
235 | 突變毒性 | 猴肝 | 10 mg/L | ||
236 | 突變毒性 | 猴腎 | 1 umol/L | ||
237 | 突變毒性 | 多種途徑 | 蛙 | 60 ppb | |
238 | 突變毒性 | 靜脈注射 | 兔 | 1 mg/kg | |
239 | 突變毒性 | 腹腔注射 | 蛙 | 125 mg/kg | |
240 | 突變毒性 | 腹腔注射 | 兔 | 11 mg/kg | |
241 | 突變毒性 | 哺乳動物淋巴細胞 | 30 umol/L | ||
242 | 突變毒性 | 哺乳動物腎 | 1 mmol/L | ||
243 | 突變毒性 | 皮膚表面 | 兔 | 100 ug/L | |
244 | 突變毒性 | 狗細胞 | 1 umol/L | ||
245 | 突變毒性 | 狗肺 | 1 umol/L | ||
246 | 突變毒性 | 腸外 | 雞 | 31 ug/kg | |
247 | 突變毒性 | 皮膚表面 | 兔 | 30 ug/L | |
248 | 突變毒性 | 兔淋巴細胞 | 10 umol/L/30M | ||
249 | 突變毒性 | 腸外 | 雞 | 31 ug/kg | |
250 | 突變毒性 | 多種途徑 | 蛙 | 10 mg/L | |
251 | 致癌性 | 口服 | 大鼠 | 15 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.胃腸道毒性——腫瘤 3.骨骼肌毒性——腫瘤 |
252 | 致癌性 | 腹腔注射 | 大鼠 | 16 mg/kg | 1.致癌性——可能致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
253 | 致癌性 | 皮下注射 | 大鼠 | 455 ug/kg/60D-I | 1.致癌性——腫瘤(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
254 | 致癌性 | 靜脈注射 | 大鼠 | 39 mg/kg/6D-I | 1.致癌性——可能致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 |
255 | 致癌性 | 肌肉注射 | 大鼠 | 2400 ug/kg | 1.致癌性——致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
256 | 致癌性 | 腦注射 | 大鼠 | 22 mg/kg | 1.致癌性——可能致癌(根據RTECS標準) 2.大腦毒性——腫瘤 3.致癌性——適用於指定部位的腫瘤 |
257 | 致癌性 | 氣管 | 大鼠 | 1200 ug/kg | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.皮膚和附件毒性——腫瘤 |
258 | 致癌性 | 注入 | 大鼠 | 150 ug/kg | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.致癌性——適用於指定部位的腫瘤 |
259 | 致癌性 | 口服 | 小鼠 | 700 mg/kg/75W-I | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.血液毒性——白血病 |
260 | 致癌性 | 吸入 | 小鼠 | 200 ng/m3/6H/13W-I | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
261 | 致癌性 | 皮膚表面 | 小鼠 | 120 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.生殖毒性——胎盤腫瘤 |
262 | 致癌性 | 皮膚表面 | 小鼠 | 28500 ug/kg/19W-I | 1.致癌性——致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 |
263 | 致癌性 | 皮膚表面 | 小鼠 | 25 ng/kg/110W-I | 1.致癌性——致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 3.致癌性——適用於指定部位的腫瘤 |
264 | 致癌性 | 腹腔注射 | 小鼠 | 10 mg/kg | 1.致癌性——腫瘤(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
265 | 致癌性 | 腹腔注射 | 小鼠 | 300 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.生殖毒性——胎盤腫瘤 3.肺部、胸部或者呼吸毒性——腫瘤 |
266 | 致癌性 | 皮下注射 | 小鼠 | 300 mg/kg | 1.致癌性——腫瘤(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.生殖毒性——呼吸系統發育異常 |
267 | 致癌性 | 皮下注射 | 小鼠 | 9 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
268 | 致癌性 | 皮下注射 | 小鼠 | 480 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.生殖毒性——胎盤腫瘤 3.肺部、胸部或者呼吸毒性——腫瘤 |
269 | 致癌性 | 靜脈注射 | 小鼠 | 10 mg/kg | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
270 | 致癌性 | 氣管 | 小鼠 | 200 mg/kg/10W-I | 1.致癌性——腫瘤(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
271 | 致癌性 | 注入 | 小鼠 | 200 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
272 | 致癌性 | 未報告 | 小鼠 | 80 mg/kg/8D-I | 1.致癌性——可能致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
273 | 致癌性 | 直腸注射 | 小鼠 | 200 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.血液毒性——白血病 3.胃腸道毒性——結腸腫瘤 |
274 | 致癌性 | 腸外 | 狗 | 819 mg/kg/26W-I | 1.致癌性——可能致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
275 | 致癌性 | 注入 | 狗 | 651 mg/kg/21W-C | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——呼吸困難 3.致癌性——適用於指定部位的腫瘤 |
276 | 致癌性 | 皮下注射 | 猴 | 40 mg/kg | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.致癌性——適用於指定部位的腫瘤 |
277 | 致癌性 | 皮膚表面 | 兔 | 17 mg/kg/57W-I | 1.致癌性——可能致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 |
278 | 致癌性 | 靜脈注射 | 兔 | 30 mg/kg | 1.致癌性——腫瘤(根據RTECS標準) 2.生殖毒性——胎盤腫瘤 3.周圍神經毒性——神經或神經鞘結構發生變化 |
279 | 致癌性 | 氣管 | 兔 | 145 mg/kg/2Y-I | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——支氣管癌 3.血液毒性——白血病 |
280 | 致癌性 | 口服 | 倉鼠 | 420 mg/kg/21W-I | 1.致癌性——可能致癌(根據RTECS標準) 2.胃腸道毒性——腫瘤 3.皮膚和附件毒性——腫瘤 |
281 | 致癌性 | 吸入 | 倉鼠 | 9500 ug/m3/4H/96W-I | 1.致癌性——可能致癌(根據RTECS標準) 2.嗅覺毒性——腫瘤 3.肺部、胸部或者呼吸毒性——腫瘤 |
282 | 致癌性 | 皮下注射 | 倉鼠 | 4000 ug/kg | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——支氣管癌 |
283 | 致癌性 | 氣管 | 倉鼠 | 64 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
284 | 致癌性 | 氣管 | 倉鼠 | 120 mg/kg/17W-I | 1.致癌性——腫瘤(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
285 | 致癌性 | 注入 | 倉鼠 | 5 mg/kg/22W-C | 1.致癌性——可能致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
286 | 致癌性 | 注入 | 蛙 | 45 mg/kg | 1.致癌性——可能致癌(根據RTECS標準) 2.肝毒性——腫瘤 3.腎、輸尿管和膀胱毒性——腎腫瘤 |
287 | 致癌性 | 注入 | 大鼠 | 500 ug/kg | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.致癌性——適用於指定部位的腫瘤 |
288 | 致癌性 | 皮膚表面 | 小鼠 | 12 mg/kg/20D-I | 1.致癌性——致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 |
289 | 致癌性 | 氣管 | 大鼠 | 200 mg/kg/15W-I | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.肝毒性——腫瘤 |
290 | 致癌性 | 皮膚表面 | 小鼠 | 26 mg/kg/65W-I | 1.致癌性——致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 |
291 | 致癌性 | 直腸注射 | 小鼠 | 560 mg/kg/14W-I | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 3.皮膚和附件毒性——腫瘤 |
292 | 致癌性 | 皮下注射 | 小鼠 | 8 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
293 | 致癌性 | 氣管 | 倉鼠 | 360 mg/kg/36W-I | 1.致癌性——致癌(根據RTECS標準) 2.肺部、胸部或者呼吸毒性——腫瘤 |
294 | 致癌性 | 肌肉注射 | 大鼠 | 3150 ug/kg | 1.致癌性——致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
295 | 致癌性 | 皮膚表面 | 小鼠 | 18 mg/kg/73W-I | 1.致癌性——致癌(根據RTECS標準) 2.皮膚和附件毒性——腫瘤 3.致癌性——適用於指定部位的腫瘤 |
296 | 致癌性 | 皮下注射 | 小鼠 | 12 mg/kg | 1.致癌性——致癌(根據RTECS標準) 2.致癌性——適用於指定部位的腫瘤 |
297 | 生殖毒性 | 口服 | 大鼠 | 40 mg/kg,雌性受孕 14 天后 | 1.生殖毒性——產生額外的胚胎結構 (如胎盤、臍帶) 2.生殖毒性——影響胎兒 |
298 | 生殖毒性 | 口服 | 大鼠 | 2 mg/kg,雌性受孕 28 天前 | 1.生殖毒性——新生兒死胎 2.生殖毒性——新生兒體重增加量減少 |
299 | 生殖毒性 | 口服 | 大鼠 | 1344 mg/kg,雌性受孕 15 天前 5 天 | 1.生殖毒性——影響新生兒活產指數 |
300 | 生殖毒性 | 腹腔注射 | 大鼠 | 60 mg/kg,雌性受孕 16-18 天后 | 1.生殖毒性——影響新生兒的生化和代謝 |
301 | 生殖毒性 | 皮下注射 | 大鼠 | 150 mg/kg,雌性受孕 6-8 天后 | 1.生殖毒性——植入後死亡率增加 2.生殖毒性——胎兒毒性(如胎兒發育不良,但不至死亡) 3.生殖毒性——胚胎或胎兒死亡 |
302 | 生殖毒性 | 肌肉注射 | 大鼠 | 2100 ug/kg,雌性受孕 15-19 天后 | 1.生殖毒性——影響新生兒的行為 |
303 | 生殖毒性 | 口服 | 小鼠 | 100 mg/kg,雌性受孕 16 天前 5 天 | 1.生殖毒性——影響母體產卵 |
304 | 生殖毒性 | 口服 | 小鼠 | 1280 mg/kg,雌性受孕 16 天前 5 天 | 1.生殖毒性——影響新生兒的生殖細胞 |
305 | 生殖毒性 | 口服 | 小鼠 | 100 mg/kg,雌性受孕 7-16 天后 | 1.生殖毒性——新生兒晚產 |
306 | 生殖毒性 | 口服 | 小鼠 | 100 mg/kg,多代s | 1.生殖毒性——影響產仔數 2.生殖毒性——雌性生育能力下降 3.生殖毒性——雄性生育能力下降 |
307 | 生殖毒性 | 口服 | 小鼠 | 75 mg/kg,雌性受孕 12-14 天后 | 1.生殖毒性——影響新生兒的生化和代謝 |
308 | 生殖毒性 | 口服 | 小鼠 | 100 mg/kg,雌性受孕 7-16 天后 | 1.生殖毒性——新生兒體重增加量減少 |
309 | 生殖毒性 | 腹腔注射 | 小鼠 | 50 mg/kg,雌性受孕 1 天前 | 1.生殖毒性——影響母體產卵 |
310 | 生殖毒性 | 腹腔注射 | 小鼠 | 1500 mg/kg,雄性配種 5 天前 | 1.生殖毒性——雄性生精功能異常 (包括遺傳物質,精子形態,精子活力和計數) |
311 | 生殖毒性 | 腹腔注射 | 小鼠 | 300 mg/kg,雌性受孕 16-18 天后 | 1.生殖毒性——免疫系統和網狀內皮系統發育異常 |
312 | 生殖毒性 | 腹腔注射 | 小鼠 | 200 mg/kg,雌性受孕 7 天后 | 1.生殖毒性——顱骨和麪部發育異常 (包括鼻/舌) 2.生殖毒性——皮膚和皮膚附件發育異常 3.生殖毒性——肌肉骨骼系統發育異常 |
313 | 生殖毒性 | 腹腔注射 | 小鼠 | 150 mg/kg,雌性受孕 8 天后 | 1.生殖毒性——新生兒死胎 |
314 | 生殖毒性 | 腹腔注射 | 小鼠 | 250 mg/kg,雌性受孕 13-17 天后 | 1.生殖毒性——影響胎兒或胚胎細胞遺傳物質 2.生殖毒性——血液和淋巴系統發育異常 (包括脾和骨髓) 3.生殖毒性——免疫系統和網狀內皮系統發育異常 |
315 | 生殖毒性 | 皮下注射 | 小鼠 | 160 mg/kg,雌性受孕 12 天后 | 1.生殖毒性——影響新生兒活產指數 2.生殖毒性——影響新生兒的生化和代謝 |
316 | 生殖毒性 | 皮下注射 | 小鼠 | 12 mg/kg,多代 | 1.生殖毒性——呼吸系統發育異常 |
317 | 生殖毒性 | 未報告 | 小鼠 | 40 ug/kg,雌性受孕 1 天前 | 1.生殖毒性——影響母體產卵 |
318 | 生殖毒性 | 腹腔注射 | 倉鼠 | 10 mg/kg,雄性配種 5 天前 | 1.生殖毒性——雄性生精功能異常 (包括遺傳物質,精子形態,精子活力和計數) 2.生殖毒性——睾丸,附睾,輸精管發生變化 |
- 參考資料
-
- 1. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 24,1969,1964
- 2. Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- : 23,288,1972
- 3. Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903- For publisher information, see JCROD : 69,103,1967
- 4. 淺析3,4-苯並芘的危害及其預防 楊美娟 農產品加工 2011-10-15
- 5. Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- : 30,323,1996
- 6. Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- : 148,126,1998
- 7. Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- : 3,86,1983
- 8. Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- : 48,13,1999
- 9. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 4,333,1978
- 10. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 5,505,1984
- 11. Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- : 44,131,1984
- 12. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 192,239,1987
- 13. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 109,183,1983
- 14. Proceedings of the International Symposium of the Princess Takamatsu Cancer Research Fund. (Japan Scientific Soc. Press, 6-2-10 Hongo, Bunkyo-ku, Tokyo 113, Japan) 1st- 1971- : 9,337,1979
- 15. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 60,395,1979
- 16. Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- : 79,5971,1982
- 17. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 135,87,1984
- 18. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 46,53,1977
- 19. Biochimica et Biophysica Acta. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1947- : 103,275,1965
- 20. Cold Spring Harbor Conferences on Cell Proliferation. (Cold Spring Harbor, NY) V.1-10, 1974- : 4,1451,1977
- 21. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 42,19,1977
- 22. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,175,1981
- 23. Proceedings, National Cancer Conference. (Philadelphia, PA) V.1-7, 1949- For publisher information, see CANCAR. : 5,39,1965
- 24. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 2,417,1981
- 25. Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- : 74,1378,1977
- 26. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 39,205,1982
- 27. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 368,235,1996
- 28. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 234,71,1990
- 29. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 290,175,1993
- 30. Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- : 23,171,1994
- 31. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 33,302,1973
- 32. Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1881- : 102,271,1983
- 33. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,414,1981
- 34. Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San Francisco, CA 94103) V.6- 1958- : 33,1576,1985
- 35. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,456,1981
- 36. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,468,1981
- 37. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 390,33,1997
- 38. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 8,41,1986
- 39. Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- : 47,147,1986
- 40. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 268,155,1992
- 41. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 292,83,1993
- 42. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 427,135,1999
- 43. Gann Monograph. (Tokyo, Japan) No.1-10, 1966- For publisher information, see GMCRDC. : 6,49,1968
- 44. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 49,81,1990
- 45. Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- : 110,159,1968
- 46. EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- : 23,51,1978
- 47. Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1972- : 32,13,1983
- 48. National Cancer Institute, Monograph. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1959- : 65,163,1984
- 49. Huanjing Kexue Xuebao. Environmental Sciences Journal. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1981- : 4,368,1984
- 50. Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- : 14,555,1985
- 51. Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology. (Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983- : 86,399,1987
- 52. Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1977- : 5,261,1981
- 53. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 4,181,1982
- 54. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 319,223,1993
- 55. Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- : 10,663,1981
- 56. Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- : 5,515,1991
- 57. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 291,93,1993
- 58. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 63,309,1979
- 59. Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- : 25,117,1984
- 60. In Vitro. (Rockville, MD) V.1-20, 1965- For publisher information, see ICDBEO. : 17,719,1981
- 61. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 13,119,1981
- 62. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 49,6503,1989
- 63. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 390,179,1997
- 64. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 38,1638,1978
- 65. Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- : 1,3,1980
- 66. Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- : 17,20,1991
- 67. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 346,49,1995
- 68. Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- : 78,6251,1981
- 69. Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- : 5,377,1991
- 70. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 38,2621,1978
- 71. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 3,195,1982
- 72. Banbury Report. (Cold Spring Harbor Laboratory, POB 100, Cold Spring Harbor, NY 11724) V.1- 1979- : 13,101,1982
- 73. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 18,11,1983
- 74. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 122,377,1983
- 75. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 140,43,1984
- 76. Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- : 79,28,1985
- 77. Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- : 33,699,1986
- 78. Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- : 20,148,1992
- 79. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 441,215,1999
- 80. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 467,21,2000
- 81. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 46,297,1977
- 82. British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- : 30,103,1974
- 83. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 113,239,1983
- 84. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 58,317,1978
- 85. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 117,47,1983
- 86. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 1,765,1980
- 87. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 40,4070,1980
- 88. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 128,221,1984
- 89. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 4,304,1982
- 90. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 182,309,1987
- 91. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 278,165,1992
- 92. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 21,87,2000
- 93. Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957- : 30,303,1983
- 94. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 43,5087,1983
- 95. Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- : 24,331,1983
- 96. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 40,1157,1980
- 97. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 3,267,1982
- 98. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 67,1303,1981
- 99. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 38,4640,1978
- 100. International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- : 28,387,1981
- 101. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 5,231,1984
- 102. Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905- : 252,6424,1977
- 103. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 18,337,1977
- 104. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 36,129,1981
- 105. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 4,297,1983
- 106. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 218,13,1989
- 107. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 3,203,1982
- 108. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 6,207,1979
- 109. Shika Kiso Igakkai Zasshi. Journal of the Japanese Association for Basic Dentistry. (Shika Kiso Igakkai, Hanayama Bldg., 1-44-2 Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1959- : 22,300,1980
- 110. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 10,393,1989
- 111. Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- : 25,86,1984
- 112. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 45,337,1985
- 113. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 241,361,1990
- 114. Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- : 34,755,1985
- 115. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 15,661,1994
- 116. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 1,155,1979
- 117. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 143,263,1985
- 118. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 419,91,1998
- 119. Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907- For publisher information, see JJCREP. : 64,637,1973
- 120. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 169,141,1986
- 121. Experimental Cell Biology. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.44- 1976- : 52,355,1984
- 122. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 93,409,1982
- 123. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 122,47,1983
- 124. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 10,1041,1989
- 125. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 5,33,1983
- 126. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 70,777,1983
- 127. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 130,53,1984
- 128. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 279,217,1992
- 129. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 234,179,1990
- 130. Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- : 17,163,1991
- 131. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,698,1981
- 132. Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- : 12(Suppl 13),103,1988
- 133. Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- : 38,99,1977
- 134. Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- : 38,75,1977
- 135. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 49,1236,1989
- 136. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 203,155,1988
- 137. International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- : 4,166,1969
- 138. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 5,659,1985
- 139. Advances in Modern Environmental Toxicology. (Senate Press, Inc., P.O. Box 252, Princeton Junction, NJ 08550) V.1- 1980- : 1,133,1980
- 140. Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- : 199,778,1978
- 141. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 62,947,1979
- 142. Colloques Internationaux du Centre National de la Recherche Scientifique. (Kluwer Academic Pub., POB 358, Accord Stn., Hingham, MA 02018) V.1- 1946- : 256,389,1977
- 143. International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- : 4,813,1969
- 144. International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- : 23,201,1979
- 145. Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1968- : 18,281,1979
- 146. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 42,1199,1982
- 147. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 44,1547,1984
- 148. Journal of UOEH (University of Occupational and Environmental Health). (Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807, Japan) V.1- 1979- : 5,147,1983
- 149. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 65,1321,1980
- 150. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 46,305,1977
- 151. Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- : 12,119,1984
- 152. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 4,155,1971/1972
- 153. Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- : 19,259,1992
- 154. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 38,4478,1978
- 155. Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- : 3,321,1983
- 156. International Journal of Cancer. (International Union Against Cancer, 3 rue du Conseil- General, 1205 Geneva, Switzerland) V.1- 1966- : 9,435,1972
- 157. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 42,1866,1982
- 158. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 8(Suppl 6),24,1986
- 159. Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- : 158,269,1978
- 160. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 2,245,1980
- 161. Japanese Journal of Medical Science and Biology. (National Institute of Health, 2-chome, Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.5- 1952- : 38,207,1985
- 162. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 224,465,1989
- 163. Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- : 219,385,1968
- 164. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,580,1981
- 165. Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- : 76,930,1979
- 166. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 241,83,1990
- 167. Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- : 72,4425,1975
- 168. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 4,318,1982
- 169. Zhonghua Zhongliu Zazhi. Chinese Journal of Oncology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1978- : 8,90,1986
- 170. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 10,419,1989
- 171. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 4,354,1982
- 172. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 39,2660,1979
- 173. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,594,1981
- 174. Toxicology In Vitro. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- : 5,511,1991
- 175. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 35,2413,1975
- 176. Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- : 1000(Sp Iss 1),18,1980
- 177. Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50; V.70-99, 1960- For publisher information, see APLMAS. : 95,380,1973
- 178. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 13,105,1976
- 179. British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- : 37,873,1978
- 180. Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- : 264,360,1976
- 181. Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- : 56,672,1966
- 182. Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- : 72,732,1976
- 183. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 77,259,1980
- 184. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 33,2837,1973
- 185. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 129,111,1984
- 186. Biochemistry. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1962- : 17,1597,1978
- 187. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 3,1283,1982
- 188. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 43,4723,1983
- 189. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 5,1,1983
- 190. Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1- 1972- : 27,277,1983
- 191. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 230,111,1990
- 192. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 6,474,1984
- 193. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 53,163,1990
- 194. Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69; V.14- 1974- : 48,1255,1991
- 195. Molecular Toxicology. (Taylor & Francis, Inc., 242 Cherry St., Philadelphia, PA USA 19106) V.1- 1987- : 1,217,1987
- 196. Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- : 1,139,1981
- 197. Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- : 2,277,1978
- 198. Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- : 4,41,1980
- 199. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 66,65,1979
- 200. Zhonghua Yufangyixue Zazhi. Chinese Journal of Preventive Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) Beginning history not known. : 17,221,1983
- 201. Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1924- : 64,1245,1979
- 202. National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. : OTS0545570
- 203. Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- : 33,25,1977
- 204. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 6,1627,1985
- 205. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 5,397,1985
- 206. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 207,69,1988
- 207. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 113,499,1983
- 208. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 44,1445,1984
- 209. Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- : 8,929,1981
- 210. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 111,209,1983
- 211. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 35,1035,1975
- 212. Polynuclear Aromatic Hydrocarbons, International Symposium, 7th, 1982, Cooke, M., and A.J. Dennis, eds., Columbus, OH, Battelle Press, 1983 : 7,845,1983
- 213. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 206,91,1988
- 214. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 45,3626,1985
- 215. Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- : 4,12,1989
- 216. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 51,151,1984
- 217. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 3,1405,1982
- 218. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 47,87,1983
- 219. Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- : 6,333,1980
- 220. Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- : 21,94,1980
- 221. Cytogenetic Assays of Environmental Mutagens, Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun & Co., 1982 : -,137,1982
- 222. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 58,321,1978
- 223. Environmental Mutagenesis. (New York, NY) V.1-9, 1979- For publisher information, see EMMUEG. : 8(Suppl 6),30,1986
- 224. Experimentelle Pathologie (1967-1980). (Jena, Ger. Dem. Rep.) V.1-18, 1967- For publisher information, see EXPADD. : 18,288,1980
- 225. British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- : 12,65,1958
- 226. Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- : 29,159,1980
- 227. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 29,506,1969
- 228. National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. : DOE/EV/03140-5
- 229. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 29,1927,1969
- 230. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 10,1285,1989
- 231. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 72,733,1984
- 232. Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- : 45(12),14,1980
- 233. Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- : 47(7),23,1982
- 234. Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- : 71,677,1971
- 235. Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981- For publisher information, see TOSCF2 : 9,297,1987
- 236. Archiv fuer Geschwulstforschung. (VEB Verlag Volk und Gesundheit Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1949- : 50,266,1980
- 237. Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) No.1- 1978- : 4,74,1980
- 238. Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- : 6,569,1980
- 239. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 55,227,1990
- 240. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 71,309,1983
- 241. Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- : 135,84,1970
- 242. Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940- For publisher information, see JJIND : 1,225,1940
- 243. Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958- : 22,269,1979
- 244. British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- : 39,761,1979
- 245. Byulleten' Eksperimental'noi Biologii i Meditsiny. Bulletin of Experimental Biology and Medicine. For English translation, see BEXBAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- : 88(11),592,1979
- 246. Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21- 1967- : 37,77,1980
- 247. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 65,921,1980
- 248. Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- : 127,594,1968
- 249. Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie. (Walter de Gruyter, Inc., 200 Saw Mill River Rd., Hawthorne, NY 10532) V.21- 1895/96- : 236,79,1935
- 250. Bulletin of Experimental Biology and Medicine (English Translation). Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.41- 1956- : 85,369,1978
- 251. Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907- For publisher information, see JJCREP. : 71,197,1980
- 252. Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903- For publisher information, see JCROD : 65,56,1962
- 253. JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978- For publisher information, see JNCIEQ. : 66,575,1981
- 254. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 32,360,1972
- 255. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 3,231,1977
- 256. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 25,271,1985
- 257. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 47,5202,1987
- 258. Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- : 20,143,1964
- 259. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 20,97,1983
- 260. Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- : 6,1483,1985
- 261. Experimental Lung Cancer: Carcinogenesis and Bioassays, International Symposium, 1974, Karbe, E., and J.F. Park, eds., Springer-Verlag New York, Inc., 1974 : -,199,1974
- 262. American Journal of Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1925- : 102,381,1981
- 263. Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975- : 20,117,1983
- 264. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 12,657,1952
- 265. Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- : 32,28,1972
- 266. Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston St., Baltimore, MD 21202) V.1- 1954- : 21,72,1980
- 267. EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- : 38,149,1981
- 268. Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907- For publisher information, see JJCREP. : 62,309,1971
- 269. Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Verlag, Heidelberger, Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.272- 1972- : 272,89,1972
- 270. Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- : 20,224,1964
- 271. DOE Symposium Series. (NTIS, 5285 Port Royal Rd., Springfield, VA 22161) No.45- 1978- : 54,410,1981
- 272. Biology of the Neonate. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.15- 1970- : 38,291,1980
- 273. Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- : 42,195,1986
- 274. Journal of Developmental Physiology. (Oxford University Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1979- : 19,67,1993
- 275. Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- : 19,37A,1979
- 276. Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- : 24,183,1981
- 277. Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- : 32,29A,1985
- 278. Pediatric Pharmacology. (New York, NY) V.1-5, 1980- For publisher information, see DPTHDL. : 1,143,1980
- 279. Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- : 1,712,1981
- 280. Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- : 20,365,1979
- 281. National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. : CONF-771017
- 282. Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- : 42,259,1994
- 283. Pediatric Pharmacology. (New York, NY) V.1-5, 1980- For publisher information, see DPTHDL. : 1,85,1980
- 284. Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- : 76,18,1984
- 285. The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 : TLV/BEI,1999
- 286. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- : 3,91,1973
- 287. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- : 32,211,1983
- 288. IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- : 7,56,1987
- 289. Teratology, Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 : -,49,1975
- 290. Advances in Cancer Research. (Academic Press, Inc., 465 S. Lincoln Dr., Troy, MO 63379) V.1- 1953- : 7,475,1963
- 291. Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- : 39,257,1977
- 292. Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin. (Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1 For publishe
- 293. Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St., New York, NY 10029) Ser 2: V.1- 1925- : 54,413,1978
- 294. Progress in Experimental Tumor Research. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.1- 1960- : 5,157,1964
- 295. Oncology 1970, Proceedings of the Tenth International Cancer Congress, Chicago, Year Book Medical Pub., 1971 : 5,257,1970
- 296. Medical and Biologic Effects of Environmental Pollutants Series, Washington, DC, National Academy of Sciences, 1972-77 : Pc,4,1972
- 297. National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. : CONF-691001
- 298. Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- : 24,129,1983
- 299. Preventive Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1972- : 9,622,1980
- 收起